Terms: = Liver cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2
135 results:
1. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, hk2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
2. USP14 exhibits high expression levels in hepatocellular carcinoma and plays a crucial role in promoting the growth of liver cancer cells through the hk2/AKT/P62 axis.
Zhang N; Zhang H; Yang X; Xue Q; Wang Q; Chang R; Zhu L; Chen Z; Liu X
BMC Cancer; 2024 Feb; 24(1):237. PubMed ID: 38383348
[TBL] [Abstract] [Full Text] [Related]
3. ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease.
Cao Z; Gao X; Meng J; Guo X; Xu J; Cui J; Zhou X
Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():38-46. PubMed ID: 38245444
[TBL] [Abstract] [Full Text] [Related]
4. Impact of glucose metabolism on PD-L1 expression in sorafenib-resistant hepatocellular carcinoma cells.
Cho S; Kim W; Yoo D; Han Y; Hwang H; Kim S; Kim J; Park S; Park Y; Jo H; Pyun JC; Lee M
Sci Rep; 2024 Jan; 14(1):1751. PubMed ID: 38243049
[TBL] [Abstract] [Full Text] [Related]
5. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with
Zhang YH; Liu XS; Gao Y; Yuan LL; Huang ZM; Zhang Y; Liu ZY; Yang Y; Liu XY; Ke CB; Pei ZJ
Lung Cancer; 2024 Feb; 188():107449. PubMed ID: 38184958
[TBL] [Abstract] [Full Text] [Related]
6. Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis.
Wang B; Pu R
World J Surg Oncol; 2023 Dec; 21(1):390. PubMed ID: 38114977
[TBL] [Abstract] [Full Text] [Related]
7. Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
Ding Z; Xu B; Zhang H; Wang Z; Sun L; Tang M; Ding M; Zhang T; Shi S
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005331
[TBL] [Abstract] [Full Text] [Related]
8. Integration with Transcriptomic and Metabolomic Analyses Reveals the
Guo Y; Liu Z; Wu Q; Li Z; Yang J; Xuan H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892405
[TBL] [Abstract] [Full Text] [Related]
9. The Apoptotic and Anti-Warburg Effects of Brassinin in PC-3 Cells via Reactive Oxygen Species Production and the Inhibition of the c-Myc, SIRT1, and β-Catenin Signaling Axis.
Kwon HH; Ahn CH; Lee HJ; Sim DY; Park JE; Park SY; Kim B; Shim BS; Kim SH
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762214
[TBL] [Abstract] [Full Text] [Related]
10. Dapagliflozin protects against doxorubicin-induced nephrotoxicity associated with nitric oxide pathway-A translational study.
Chang WT; Wu CC; Liao IC; Lin YW; Chen YC; Ho CH; Lee WC; Lin YC; Chen ZC; Shih JY; Wu NC; Kan WC
Free Radic Biol Med; 2023 Nov; 208():103-111. PubMed ID: 37549754
[TBL] [Abstract] [Full Text] [Related]
11. Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2.
Zheng Y; Zhan Y; Zhang Y; Zhang Y; Liu Y; Xie Y; Sun Y; Qian J; Ding Y; Ding Y; Fang Y
Cell Death Dis; 2023 Aug; 14(8):488. PubMed ID: 37524692
[TBL] [Abstract] [Full Text] [Related]
12. Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling.
He H; Guo J; Hu Y; Zhang H; Li X; Zhang J; Jin S
Acta Biochim Biophys Sin (Shanghai); 2023 Jul; 55(9):1404-1414. PubMed ID: 37489008
[TBL] [Abstract] [Full Text] [Related]
13. Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma.
Peng M; Li H; Cao H; Huang Y; Yu W; Shen C; Gu J
J Gastroenterol; 2023 Sep; 58(9):908-924. PubMed ID: 37433897
[TBL] [Abstract] [Full Text] [Related]
14. Synthesis, characterization, and cytotoxicity analysis of selenium nanoparticles stabilized by Morchella sextelata polysaccharide.
Shi M; Deng J; Min J; Zheng H; Guo M; Fan X; Cheng S; Zhang S; Ma X
Int J Biol Macromol; 2023 Jul; 242(Pt 3):125143. PubMed ID: 37247714
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive analysis of FOXM1 immune infiltrates, m6a, glycolysis and ceRNA network in human hepatocellular carcinoma.
Xu Z; Pei C; Cheng H; Song K; Yang J; Li Y; He Y; Liang W; Liu B; Tan W; Li X; Pan X; Meng L
Front Immunol; 2023; 14():1138524. PubMed ID: 37234166
[TBL] [Abstract] [Full Text] [Related]
16. LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.
Su CT; See DHW; Huang YJ; Jao TM; Liu SY; Chou CY; Lai CF; Lin WC; Wang CY; Huang JW; Hung KY
Circ Res; 2023 Jun; 133(1):71-85. PubMed ID: 37232163
[TBL] [Abstract] [Full Text] [Related]
17. A comparative study of [
Xi Y; Sun L; Che X; Huang X; Liu H; Wang Q; Meng H; Miao Y; Qu Q; Hai W; Li B; Feng W
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2885-2898. PubMed ID: 37093313
[TBL] [Abstract] [Full Text] [Related]
18. Cathepsin H Knockdown Reverses Radioresistance of Hepatocellular Carcinoma via Metabolic Switch Followed by Apoptosis.
Chen Q; Qu S; Liang Z; Liu Y; Chen H; Ma S; Liu X
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982347
[TBL] [Abstract] [Full Text] [Related]
19. lncRNA miR4458HG modulates hepatocellular carcinoma progression by activating m6A-dependent glycolysis and promoting the polarization of tumor-associated macrophages.
Ye Y; Wang M; Wang G; Mai Z; Zhou B; Han Y; Zhuang J; Xia W
Cell Mol Life Sci; 2023 Mar; 80(4):99. PubMed ID: 36933158
[TBL] [Abstract] [Full Text] [Related]
20. LINC00365 functions as a tumor suppressor by inhibiting HIF-1α-mediated glucose metabolism reprogramming in breast cancer.
Liu B; Qu X; Wang J; Xu L; Zhang L; Xu B; Su J; Bian X
Exp Cell Res; 2023 Apr; 425(1):113514. PubMed ID: 36804531
[TBL] [Abstract] [Full Text] [Related]
[Next]
